Heather Trantham-Davidson
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prefrontal Cortex | 12 | 2019 | 639 | 2.330 |
Why?
|
| Synaptic Transmission | 6 | 2019 | 236 | 1.690 |
Why?
|
| Dopamine | 4 | 2016 | 474 | 1.240 |
Why?
|
| Ethanol | 7 | 2016 | 892 | 1.060 |
Why?
|
| Receptors, Dopamine | 3 | 2016 | 119 | 0.920 |
Why?
|
| Pyramidal Cells | 6 | 2019 | 79 | 0.880 |
Why?
|
| Glutamic Acid | 3 | 2015 | 332 | 0.840 |
Why?
|
| Dysbindin | 3 | 2019 | 9 | 0.760 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2014 | 109 | 0.710 |
Why?
|
| GABAergic Neurons | 1 | 2019 | 17 | 0.690 |
Why?
|
| Cocaine | 4 | 2013 | 555 | 0.640 |
Why?
|
| Extinction, Psychological | 4 | 2014 | 240 | 0.620 |
Why?
|
| Neostriatum | 2 | 2015 | 60 | 0.610 |
Why?
|
| Alcoholism | 2 | 2015 | 1109 | 0.580 |
Why?
|
| Dendritic Spines | 1 | 2016 | 76 | 0.560 |
Why?
|
| Neuronal Plasticity | 2 | 2015 | 274 | 0.530 |
Why?
|
| Alcoholic Intoxication | 1 | 2015 | 61 | 0.530 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2014 | 10 | 0.490 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 5 | 2019 | 266 | 0.480 |
Why?
|
| Conditioning, Operant | 3 | 2014 | 241 | 0.480 |
Why?
|
| Cognition | 2 | 2015 | 512 | 0.460 |
Why?
|
| Excitatory Postsynaptic Potentials | 4 | 2016 | 87 | 0.440 |
Why?
|
| Ceftriaxone | 1 | 2012 | 32 | 0.440 |
Why?
|
| Animals | 21 | 2019 | 20877 | 0.430 |
Why?
|
| Cognition Disorders | 1 | 2015 | 342 | 0.430 |
Why?
|
| Interneurons | 2 | 2016 | 70 | 0.430 |
Why?
|
| Exploratory Behavior | 2 | 2014 | 79 | 0.420 |
Why?
|
| Action Potentials | 4 | 2016 | 223 | 0.420 |
Why?
|
| Patch-Clamp Techniques | 5 | 2019 | 204 | 0.360 |
Why?
|
| Nucleus Accumbens | 1 | 2012 | 417 | 0.340 |
Why?
|
| Hyperkinesis | 1 | 2008 | 8 | 0.320 |
Why?
|
| Rats | 9 | 2016 | 5300 | 0.320 |
Why?
|
| Receptors, Dopamine D1 | 2 | 2007 | 87 | 0.320 |
Why?
|
| Neural Inhibition | 2 | 2007 | 80 | 0.320 |
Why?
|
| Prosencephalon | 1 | 2008 | 38 | 0.320 |
Why?
|
| Rats, Long-Evans | 4 | 2016 | 203 | 0.310 |
Why?
|
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2007 | 1 | 0.310 |
Why?
|
| Brain | 2 | 2015 | 2175 | 0.310 |
Why?
|
| Impulsive Behavior | 1 | 2008 | 85 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2015 | 2083 | 0.280 |
Why?
|
| Central Nervous System Depressants | 3 | 2016 | 182 | 0.260 |
Why?
|
| Long-Term Synaptic Depression | 2 | 2015 | 32 | 0.240 |
Why?
|
| Neurons | 3 | 2016 | 881 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 2790 | 0.230 |
Why?
|
| Membrane Proteins | 1 | 2008 | 617 | 0.230 |
Why?
|
| Mice, Knockout | 4 | 2019 | 1692 | 0.220 |
Why?
|
| Male | 16 | 2019 | 37281 | 0.220 |
Why?
|
| Mice | 8 | 2019 | 8472 | 0.210 |
Why?
|
| Organ Culture Techniques | 3 | 2014 | 122 | 0.210 |
Why?
|
| Self Administration | 5 | 2015 | 419 | 0.200 |
Why?
|
| Cerebral Cortex | 1 | 2004 | 415 | 0.200 |
Why?
|
| Receptors, AMPA | 3 | 2016 | 99 | 0.190 |
Why?
|
| Memory, Short-Term | 2 | 2010 | 79 | 0.180 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2019 | 25 | 0.180 |
Why?
|
| Signal Transduction | 2 | 2004 | 2688 | 0.160 |
Why?
|
| gamma-Aminobutyric Acid | 3 | 2016 | 208 | 0.150 |
Why?
|
| Carrier Proteins | 2 | 2010 | 597 | 0.150 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 2 | 2014 | 51 | 0.140 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2016 | 71 | 0.140 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2016 | 31 | 0.140 |
Why?
|
| Potassium Channels | 1 | 2016 | 55 | 0.140 |
Why?
|
| Pharmacogenetics | 1 | 2016 | 47 | 0.140 |
Why?
|
| Neural Pathways | 2 | 2015 | 323 | 0.140 |
Why?
|
| Receptors, GABA-A | 1 | 2016 | 89 | 0.130 |
Why?
|
| Frontal Lobe | 1 | 2016 | 156 | 0.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2004 | 93 | 0.120 |
Why?
|
| Affect | 1 | 2015 | 218 | 0.120 |
Why?
|
| Drug-Seeking Behavior | 2 | 2014 | 213 | 0.120 |
Why?
|
| Reward | 1 | 2015 | 201 | 0.120 |
Why?
|
| Photic Stimulation | 1 | 2014 | 229 | 0.120 |
Why?
|
| Electrophysiology | 2 | 2004 | 160 | 0.120 |
Why?
|
| Basal Ganglia | 1 | 2013 | 45 | 0.110 |
Why?
|
| Methamphetamine | 1 | 2015 | 132 | 0.110 |
Why?
|
| Executive Function | 1 | 2014 | 106 | 0.110 |
Why?
|
| Receptors, Glycine | 1 | 2013 | 9 | 0.110 |
Why?
|
| Thiazoles | 1 | 2013 | 95 | 0.110 |
Why?
|
| Central Nervous System Stimulants | 1 | 2015 | 221 | 0.110 |
Why?
|
| Random Allocation | 1 | 2014 | 442 | 0.110 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 213 | 0.110 |
Why?
|
| Learning | 1 | 2014 | 186 | 0.110 |
Why?
|
| Pyridines | 1 | 2013 | 261 | 0.100 |
Why?
|
| Behavior, Addictive | 1 | 2014 | 317 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 805 | 0.090 |
Why?
|
| Anxiety | 2 | 2014 | 422 | 0.090 |
Why?
|
| In Vitro Techniques | 2 | 2013 | 765 | 0.080 |
Why?
|
| Cocaine-Related Disorders | 1 | 2013 | 504 | 0.080 |
Why?
|
| Calbindins | 1 | 2007 | 23 | 0.080 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 2007 | 21 | 0.080 |
Why?
|
| Avoidance Learning | 1 | 2008 | 58 | 0.080 |
Why?
|
| Parvalbumins | 1 | 2007 | 29 | 0.080 |
Why?
|
| Amygdala | 1 | 2008 | 159 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 1745 | 0.070 |
Why?
|
| Schizophrenia | 1 | 2007 | 206 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2008 | 682 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 1032 | 0.060 |
Why?
|
| Receptors, Glutamate | 1 | 2004 | 22 | 0.060 |
Why?
|
| Adenylyl Cyclases | 1 | 2004 | 94 | 0.060 |
Why?
|
| Hippocampus | 1 | 2008 | 471 | 0.060 |
Why?
|
| Type C Phospholipases | 1 | 2004 | 67 | 0.060 |
Why?
|
| Motor Activity | 1 | 2008 | 621 | 0.060 |
Why?
|
| Ion Channels | 1 | 2004 | 72 | 0.060 |
Why?
|
| Electric Stimulation | 1 | 2004 | 218 | 0.060 |
Why?
|
| GTP-Binding Proteins | 1 | 2004 | 231 | 0.060 |
Why?
|
| Mice, Inbred DBA | 2 | 2016 | 120 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2016 | 954 | 0.050 |
Why?
|
| Biomarkers | 1 | 2007 | 1593 | 0.050 |
Why?
|
| Memory Disorders | 2 | 2015 | 111 | 0.050 |
Why?
|
| Humans | 3 | 2015 | 68525 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 567 | 0.050 |
Why?
|
| Dystrophin-Associated Proteins | 2 | 2010 | 7 | 0.050 |
Why?
|
| Models, Biological | 1 | 2004 | 981 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 2550 | 0.040 |
Why?
|
| Phenylenediamines | 1 | 2016 | 16 | 0.040 |
Why?
|
| Membrane Transport Modulators | 1 | 2016 | 23 | 0.040 |
Why?
|
| Carbamates | 1 | 2016 | 41 | 0.040 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2015 | 20 | 0.030 |
Why?
|
| Cycloserine | 1 | 2015 | 30 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2015 | 62 | 0.030 |
Why?
|
| Phenols | 1 | 2015 | 73 | 0.030 |
Why?
|
| Piperidines | 1 | 2015 | 123 | 0.030 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2015 | 92 | 0.030 |
Why?
|
| Reinforcement Schedule | 1 | 2014 | 59 | 0.030 |
Why?
|
| Central Nervous System Agents | 1 | 2014 | 37 | 0.030 |
Why?
|
| Maze Learning | 1 | 2014 | 138 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2014 | 187 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2013 | 20 | 0.030 |
Why?
|
| Biotinylation | 1 | 2013 | 27 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2014 | 371 | 0.030 |
Why?
|
| Sucrose | 1 | 2013 | 58 | 0.030 |
Why?
|
| Glycine Agents | 1 | 2013 | 5 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2013 | 58 | 0.030 |
Why?
|
| Strychnine | 1 | 2013 | 14 | 0.030 |
Why?
|
| Picrotoxin | 1 | 2013 | 14 | 0.030 |
Why?
|
| Bicuculline | 1 | 2013 | 17 | 0.030 |
Why?
|
| Microinjections | 1 | 2013 | 130 | 0.030 |
Why?
|
| GABA Antagonists | 1 | 2013 | 22 | 0.030 |
Why?
|
| Benzamides | 1 | 2014 | 156 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2014 | 190 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2013 | 334 | 0.030 |
Why?
|
| Locomotion | 1 | 2013 | 135 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2014 | 211 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2013 | 289 | 0.030 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2013 | 152 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1039 | 0.020 |
Why?
|
| Recurrence | 1 | 2013 | 948 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1293 | 0.020 |
Why?
|
| Motivation | 1 | 2014 | 561 | 0.020 |
Why?
|
| Presynaptic Terminals | 1 | 2009 | 34 | 0.020 |
Why?
|
| Space Perception | 1 | 2009 | 44 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 2009 | 61 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2009 | 200 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 447 | 0.020 |
Why?
|
| Cues | 1 | 2013 | 654 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 517 | 0.020 |
Why?
|
| Synapses | 1 | 2009 | 222 | 0.020 |
Why?
|
| Female | 2 | 2016 | 38015 | 0.010 |
Why?
|